A Maori-led trial of lung cancer screening is a first for New Zealand
A Maori-led trial of lung cancer screening is a first for New Zealand
20 May 2021
The trial will be based at the Waitemata DHB, and try to develop a screening process that slashes the stark inequities of cancer incidences between Maori and non-Maori.
Lung cancer is the single biggest factor in the difference in life expectancy between Maori and non-Maori.
Trial leader Professor Sue Crengle says the screening programme needs to be Maori-focused from the get-go.
She says lung cancer is a major public health and equity issue in New Zealand.
© 2024 Newstalk ZB, NZCity